Salt Lake City, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rob Hitchcock has been named as president and chief executive officer for #" Rob Hitchcock Rob Hitchcock, President and CEO, SelectHealth
Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma 15-02-2023, 21:25